Tilray, Sandoz have new agreement for developing market for medical cannabis

NANAIMO, B.C. — Marijuana company Tilray Canada Ltd. has signed a new agreement to collaborate with Sandoz AG, part of the Novartis pharmaceutical group.
The companies say they will work together to increase the availability of high quality medical cannabis products across the world.
They say it’s an evolution of an existing alliance between Tilray and Sandoz Canada. Financial terms weren’t disclosed.
Under the new agreement, Sandoz may support Tilray’s commercialization